₹ 14700 / 105 shares

IPO Details

Issue Date

--

Investment/lot

₹ 14700

Price Range

140

Lot Size

105

IPO Size

₹ 152.46 Cr

IPO Listing Details

Listing On

6 Oct'23

Issue Price

--

Listed Price

₹ 162.15

Retail Gain/Listing Gain

15.82%

Start date

End date

Allotment of bids

Refund Initiation

Listing on exchange

Valiant Laboratories Limited is an active pharmaceutical ingredient (API)/bulk drug manufacturing company, with a focus on manufacturing Paracetamol. Bulk drugs/APIs serve as raw materials for manufacturing finished dosage forms or formulations.

India is the largest provider of generic drugs, globally contributing to approximately 20% of global supply by volume of generic drugs. The overall API industry in India grew from Rs. 781 billion in fiscal 2017 to Rs. 1,179 billion in fiscal 2022, registering a CAGR of 8.5% in rupee terms. Going forward, the API industry is expected to grow at a rate of 9-11% between fiscal 2022 and 2027, largely driven by the increase in API exports. More specifically, the paracetamol API industry (domestic + exports) grew from Rs. 22 billion in fiscal 2017 to Rs. 39 billion in fiscal 2023.

Read More
Strong financial performance
Read More
Reducing dependence on imported raw materials
Read More
Strategically located manufacturing facility
Read More
  • Any changes to the paracetamol API industry or the company’s product demand will adversely affect revenues, financials and profitability.
  • The company is dependent on a single manufacturing facility.
  • The company must always be subject to strict quality requirements, regular inspections and audits.
  • Diversification into new chemistries.
  • Increase penetration into international markets including regulated markets.
  • Improve operational efficiencies through backward integration of the proposed facility.

Here are the key financials for Valiant Laboratories Limited:

Particulars (in Rs. million)

Particulars (in Rs. million)

What are you looking for?
Applying for an IPO for the first time?
Here's a video playlist to help you invest in the upcoming Valiant Laboratories Limited IPO
How to apply for IPO through ASBA

How to apply for IPO through ASBA

Kotak Securities

00m 59s

Top Valiant Laboratories Ltd IPO FAQs

Valiant Laboratories Ltd will list on 2023-10-06.

152.46 is the issue size of Valiant Laboratories Ltd IPO.

The minimum lot size is 105 shares and the investment required is ₹14700.

The price band of Valiant Laboratories Ltd IPO is ₹140 to ₹0.

The Valiant Laboratories Limited IPO has an issue size of Rs. 152.46 crores. The IPO opens for subscription on 27th September and closes on 3rd October 2023.

Link Intime India Private Limited is the registrar for this IPO.

You may read more about Valiant Laboratories Limited and its IPO from the company’s red herring prospectus (RHP) here:

Open Demat Account to Invest in any IPO
+91 -

personImage